Emily Bongard

1.3k total citations
27 papers, 804 citations indexed

About

Emily Bongard is a scholar working on Epidemiology, Public Health, Environmental and Occupational Health and Infectious Diseases. According to data from OpenAlex, Emily Bongard has authored 27 papers receiving a total of 804 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 9 papers in Public Health, Environmental and Occupational Health and 7 papers in Infectious Diseases. Recurrent topics in Emily Bongard's work include Bacterial Identification and Susceptibility Testing (5 papers), Malaria Research and Control (5 papers) and Influenza Virus Research Studies (4 papers). Emily Bongard is often cited by papers focused on Bacterial Identification and Susceptibility Testing (5 papers), Malaria Research and Control (5 papers) and Influenza Virus Research Studies (4 papers). Emily Bongard collaborates with scholars based in United Kingdom, Netherlands and Belgium. Emily Bongard's co-authors include Livia Vivas, Mramba Nyindo, Stephen H. Gillespie, L. Uiso, Esther Kanduma, Richard Morris, Noel E. Sam, Roly Gosling, Sarah C. Charnaud and Tirayut Vilaivan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, American Journal of Respiratory and Critical Care Medicine and Journal of Medicinal Chemistry.

In The Last Decade

Emily Bongard

26 papers receiving 779 citations

Peers

Countries citing papers authored by Emily Bongard

Since Specialization

Citations

This map shows the geographic impact of Emily Bongard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Bongard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Bongard more than expected).

Fields of papers citing papers by Emily Bongard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emily Bongard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Bongard. The network helps show where Emily Bongard may publish in the future.

Co-authorship network of co-authors of Emily Bongard

This figure shows the co-authorship network connecting the top 25 collaborators of Emily Bongard. A scholar is included among the top collaborators of Emily Bongard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emily Bongard. Emily Bongard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Conditional versus non-conditional incentives to maximise return of participant completed questionnaires in clinical trials: a cluster randomised study within a trial 2023 ·Trials ·(unknown), Jonathan Cook, Emily Bongard, Carl Heneghan, Christopher Butler	1
2	Clinical diagnosis of SARS-CoV-2 infection: An observational study of respiratory tract infection in primary care in the early phase of the pandemic 2023 ·European Journal of General Practice ·Alike W. van der Velden, Milensu Shanyinde, Emily Bongard, Femke Böhmer, Sławomir Chlabicz, Annelies Colliers, (unknown), Lile Malania, József Pauer, (unknown), Ly‐Mee Yu, Katherine Loens, Margareta Ieven, Theo Verheij, Herman Goossens, Akke Vellinga, Christopher Butler	3
3	Mixed-methods evaluation of a behavioural intervention package to identify and amend incorrect penicillin allergy records in UK general practice 2022 ·BMJ Open ·Marta Wanat, (unknown), Ushma Galal, Mina Davoudianfar, Emily Bongard, Sinisa Savic, Louise Savic, (unknown), (unknown), Christopher Butler, Sue Pavitt, Jonathan Sandoe, Sarah Tonkin‐Crine	4
4	Direct and Indirect Costs of Influenza-Like Illness Treated with and Without Oseltamivir in 15 European Countries: A Descriptive Analysis Alongside the Randomised Controlled ALIC4E Trial 2021 ·Clinical Drug Investigation ·Xiao Li, Joke Bilcke, Alike W. van der Velden, Emily Bongard, Robin Bruyndonckx, Pär‐Daniel Sundvall, (unknown), Samuel Coenen, Nick Francis, (unknown), (unknown), Dominik Glinz, (unknown), (unknown), (unknown), Bohumil Seifert, Nikolaos Tsakountakis, Rune Aabenhus, Christopher Butler, Philippe Beutels	3
5	Diagnostic performance of the Idylla™ respiratory panel for molecular detection of influenza A/B in patients presenting to primary care with influenza-like illness during 3 consecutive influenza seasons 2021 ·Journal of Clinical Virology ·(unknown), Katherine Loens, (unknown), Kevin A. Jacobs, Samuel Coenen, Alike W. van der Velden, Emily Bongard, Christopher Butler, Theo Verheij, Herman Goossens, Margareta Ieven	0
6	Developing a behavioural intervention package to identify and amend incorrect penicillin allergy records in UK general practice and subsequently change antibiotic use 2020 ·BMJ Open ·(unknown), Marta Wanat, Mina Davoudianfar, Emily Bongard, Sinisa Savic, Louise Savic, (unknown), (unknown), Christopher Butler, Sue Pavitt, Jonathan Sandoe, Sarah Tonkin‐Crine	13
7	Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomised controlled trial in European primary care from 2016 to 2018 2020 ·British Journal of General Practice ·Samuel Coenen, Alike W. van der Velden, Daniela Cianci, Herman Goossens, Emily Bongard, Benjamin R. Saville, Nina Gobat, (unknown), Margareta Ieven, Theo Verheij, Christopher Butler	11
8	A trial like ALIC⁴E: why design a platform, response-adaptive, open, randomised controlled trial of antivirals for influenza-like illness? 2018 ·ERJ Open Research ·Christopher Butler, Samuel Coenen, Benjamin R. Saville, Johanna Cook, Alike W. van der Velden, (unknown), Menno D. de Jong, Paul Little, Herman Goossens, Philippe Beutels, Margareta Ieven, Nick Francis, Pieter Moons, Emily Bongard, Theo Verheij	14
9	Patient understanding and acceptability of an early lung cancer diagnosis trial: a qualitative study 2018 ·Trials ·Hayley Prout, (unknown), Emily Bongard, Rhiannon Tudor Edwards, Gareth Griffiths, William Hamilton, Emily Harrop, Kerenza Hood, Chris Hurt, (unknown), (unknown), Kirsty Roberts, Trevor Rogers, Emma Thomas‐Jones, Angela Tod, Seow Tien Yeo, Richard D Neal, Annmarie Nelson	10
10	Spot sputum samples are at least as good as early morning samples for identifying Mycobacterium tuberculosis 2017 ·BMC Medicine ·Michael E. Murphy, Patrick Phillips, Carl M. Mendel, Emily Bongard, (unknown), Robert Hunt, (unknown), Kasha P. Singh, Michael Brown, Angela M. Crook, Andrew Nunn, Sarah Meredith, Marc Lipman, Timothy D. McHugh, Stephen H. Gillespie	8
11	Immediate chest X-ray for patients at risk of lung cancer presenting in primary care: randomised controlled feasibility trial 2017 ·British Journal of Cancer ·Richard D Neal, (unknown), Emily Bongard, Rhiannon Tudor Edwards, Jim Fitzgibbon, Gareth Griffiths, William Hamilton, Kerenza Hood, Annmarie Nelson, David Parker, (unknown), Hayley Prout, Kirsty Roberts, Trevor Rogers, Emma Thomas‐Jones, Angela Tod, Seow Tien Yeo, Chris Hurt	13
12	Analytic laboratory performance of a point of care urine culture kit for diagnosis and antibiotic susceptibility testing 2015 ·European Journal of Clinical Microbiology & Infectious Diseases ·Emily Bongard, Jens Kjølseth Møller, Micaela Gal, Mandy Wootton, Robin Howe, Nick Francis, Herman Goossens, Christopher Butler	14
13	A portable system for identifying urinary tract infection in primary care using a PC-based chromatic technique 2014 ·Physiological Measurement ·(unknown), Gareth‐Rhys Jones, J. W. Spencer, Emily Bongard, Micaela Gal, (unknown), Christopher Butler	1
14	Effects of an optimised POCT guided diagnostic and treatment strategy for symptoms of uncomplicated UTI on use of appropriate antibiotics and uptake into primary care practice 2013 ·Trials ·Janine Bates, Emma Thomas‐Jones, Nigel Kirby, Timothy Pickles, Rhys H. Thomas, Emily Bongard, Micaela Gal, Paul Little, Theo Verheij, Carl Llor, David Cohen, Nick Francis, Kerenza Hood, Christopher Butler	1
15	Synthesis and structure–activity relationship of 3-phenylquinoxaline 1,4-di-N-oxide derivatives as antimalarial agents 2008 ·European Journal of Medicinal Chemistry ·Esther Vicente, Lı́dia Moreira Lima, Emily Bongard, Sarah C. Charnaud, Raquel Villar, Beatriz Solano, Asunción Burguete, Silvia Pérez‐Silanes, Ignacio Aldana, Livia Vivas	57
16	Malaria diagnosis under field conditions in the Venezuelan Amazon 2007 ·Transactions of the Royal Society of Tropical Medicine and Hygiene ·Wolfram Metzger, Sarai Vivas-Martínez, (unknown), (unknown), Emily Bongard, Caterina Fanello, Livia Vivas, (unknown)	20
17	Anti-malarial activity of N6-modified purine analogues 2007 ·Bioorganic & Medicinal Chemistry ·(unknown), D. M. Brown, Emily Bongard, Vanessa Yardley, Livia Vivas, David Loakes	27
18	Anti-malarial efficacy of pyronaridine and artesunate in combination in vitro and in vivo 2007 ·Acta Tropica ·Livia Vivas, Lauren Rattray, Lindsay B. Stewart, Emily Bongard, B. L. Robinson, Wallace Peters, Simon L. Croft	46
19	In Vitro Anti-Malarial Activity Of N⁶-Modified Purine Analogs 2007 ·Nucleosides Nucleotides & Nucleic Acids ·(unknown), D. M. Brown, David Loakes, Emily Bongard, Livia Vivas	2
20	The Bactericidal Activity of Moxifloxacin in Patients with Pulmonary Tuberculosis 2003 ·American Journal of Respiratory and Critical Care Medicine ·Roly Gosling, L. Uiso, Noel E. Sam, Emily Bongard, Esther Kanduma, Mramba Nyindo, Richard Morris, Stephen H. Gillespie	119

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact